Table 1.

The effect of IC87114 on the activity of several protein kinases and a phosphatase


Enzyme

Activity (% of control) ± SD
EGF receptor tyrosine kinase   102 ± 5.5  
Insulin receptor tyrosine kinase   98 ± 6.2  
CD45 tyrosine phosphatase   104 ± 2.2  
PKC-θ   97 ± 5.5  
PDK1   91.5 ± 2.1  
Lck   116.5 ± 9.2  
P70S6K   98.5 ± 0.7  
CDK2/cyclinA   92.5 ± 2.12  
ZAP-70   97.5 ± 13.4  
p38 MAPK   No inhibition* 
DNA-PK   No inhibition* 
CHK1   No inhibition* 
cSrc   No inhibition* 
CK1   No inhibition* 
PKBα (Akt 1)   No inhibition* 
PKCα   No inhibition* 
PKCβII
 
No inhibition*
 

Enzyme

Activity (% of control) ± SD
EGF receptor tyrosine kinase   102 ± 5.5  
Insulin receptor tyrosine kinase   98 ± 6.2  
CD45 tyrosine phosphatase   104 ± 2.2  
PKC-θ   97 ± 5.5  
PDK1   91.5 ± 2.1  
Lck   116.5 ± 9.2  
P70S6K   98.5 ± 0.7  
CDK2/cyclinA   92.5 ± 2.12  
ZAP-70   97.5 ± 13.4  
p38 MAPK   No inhibition* 
DNA-PK   No inhibition* 
CHK1   No inhibition* 
cSrc   No inhibition* 
CK1   No inhibition* 
PKBα (Akt 1)   No inhibition* 
PKCα   No inhibition* 
PKCβII
 
No inhibition*
 

The selectivity of IC87114 (10 μM) was tested against several human protein kinases and a phosphatase. Protein kinase assays were performed in the presence of 100 μMATP.

EGF indicates epidermal growth factor; PKC, protein kinase C; PKB, protein kinase B; PK, protein kinase; CHK1, checkpoint kinase 1; and CK, casein kinase-1.

*

Sadhu et al.24 

or Create an Account

Close Modal
Close Modal